Example: Heart Attack

Search clinical trials for: Antimitotic Agents

Total 6532 results

NCT02087176

Terminated

A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer

Conditions: Previously Treated Non Small Cell Lung Cancer
NCT01649336

Completed

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
NCT04168788

Not yet recruiting

Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL

Conditions: Hepatic Veno-Occlusive Disease; Nephroblastoma; Acute Lymphoblastic Leukemia
NCT00833326

Completed

A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer

Conditions: Advanced Cancer
NCT00661609

Completed

A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer

Conditions: Bladder Cancer; Transitional Cell Bladder Cancer; Urethra Cancer; Ureter Cancer; Renal Pelvis Cancer
NCT00504790

Completed

Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer

Conditions: Cancer
NCT02155439

Completed

Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot Study

Conditions: Keloidscars
NCT00014430

Completed

Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer

Conditions: Breast Cancer
NCT00970580

Completed

A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer

Conditions: Non-Small Cell Lung Cancer
NCT00547261

Terminated

Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer

Conditions: Neoplasms
NCT00821249

Completed

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

Conditions: Multiple Myeloma; Plasma Cell Leukemia
NCT03574753

Active, not recruiting

Lung-MAP S1400K: c-MET Positive

Conditions: Recurrent Squamous Cell Lung Carcinoma; Stage IV Squamous Cell Lung Carcinoma AJCC V7
NCT02341456

Completed

Phase Ib Study AZD1775 in Combination With Carboplatin and Paclitaxel in Adult Asian Patients With Solid Tumours

Conditions: Advanced Solid Tumours
NCT01248923

Completed

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Conditions: Multiple Myeloma, Plasma Cell Leukemia
NCT01849874

Active, not recruiting

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

Conditions: Low-grade Serous Ovarian Cancer; Low-grade Serous Fallopian Tube Cancer; Low-grade Serous Peritoneal Cancer
NCT00367471

Completed

Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer.

Conditions: Neoplasms, Breast
NCT01764087

Unknown status

A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors

Conditions: Unspecified Adult Solid Tumor, Protocol Specific; Gastric Cancer; Breast Cancer
NCT02061085

Completed

Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment

Conditions: Breast Neoplasm; Metastasis
NCT03961698

Recruiting

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma (MARIO-3)

Conditions: Breast Cancer; Renal Cell Carcinoma
NCT04177108

Recruiting

A Study Of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer.

Conditions: Triple-Negative Breast Cancer
NCT02855359

Terminated

Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Conditions: Diffuse, Large B-Cell, Lymphoma; Follicular Lymphoma, Grade 3b; Transformed Lymphoma / DLBCL
NCT02834403

Recruiting

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Conditions: Metastatic Triple Negative Breast Cancer
NCT01372540

Completed

Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Conditions: Plasma Cell Leukemia; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
NCT00637052

Completed

A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia

Conditions: Advanced MDS; Acute Myeloid Leukemia
NCT02922764

Recruiting

A Study of RGX-104 in Patients With Advanced Solid Malignancies and Lymphoma

Conditions: Malignant Neoplasms